You are here: For the applicantsCoronavirusInternational news
Funding for vaccine development
08 April 2020
Last modified: 08 April 2020
Reading time: 1 minute(s)
On 16 March, the European Commission offered up to €80 million of financial support to CureVac, a highly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe.

On 16 March, the European Commission offered up to €80 million of financial support to CureVac, a highly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe. CureVac was previously the recipient of the EU's first inducement prize in 2014 for its innovative vaccine technology.

More information: https://ec.europa.eu/

Updated: 08 April 2020
Feedback
Was this page helpful?